FHMLS IX, L.L.C.'s Net Worth

Estimate Recalculated Oct 8, 2025 09:11PM EST

Who is FHMLS IX, L.L.C.

FHMLS IX, L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tarsus Pharmaceuticals, Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., and Passage BIO, Inc..

SEC CIK

FHMLS IX, L.L.C.'s CIK is 0001782791

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Tarsus Pharmaceuticals, Inc.

Investor

Updated Oct 20, 2020

View Quote Details


Form 4	19.47%	312.50K	$16.00	—	Oct 20, 2020	1.92M	Purchase	—	Oct 20
Form 3	—	—	—	—	Oct 15, 2020	—	—	—	—

Showing 2 results

Phathom Pharmaceuticals, Inc.

Investor

Updated Jun 16, 2020

View Quote Details


Form 4	-20.00%	-1.46M	—	—	Jun 16, 2020	5.86M	Disposition	—	Jun 12
Form 4	16.89%	1.05M	$16.86	$40.58M	Oct 30, 2019	7.28M	Purchase	—	Oct 29
Form 3	—	—	—	—	Oct 24, 2019	4.88M	—	—	—

Showing 3 results

Mirum Pharmaceuticals, Inc.

Investor

Updated Jul 24, 2019

View Quote Details


Form 4	-85.70%	-21.37M	$15.00	—	Jul 24, 2019	3.57M	Buy-Options	—	Jul 22
Form 3	—	—	—	—	Jul 17, 2019	—	—	—	—

Showing 2 results

Passage BIO, Inc.

Investor

Updated Mar 03, 2020

View Quote Details


Form 4	12.33%	550.00K	$18.00	—	Mar 03, 2020	5.01M	Purchase	—	Mar 03
Form 3	—	—	—	—	Feb 27, 2020	—	—	—	—

Showing 2 results